Bibliographic Analysis: Pelvic Inflammatory Disease (PID)

Introduction: Pelvic inflammatory disease (PID) is a serious infection of the female upper reproductive tract and remains a major global public health problem due to its association with infertility, ectopic pregnancy, chronic pelvic pain, and recurrent reproductive tract infections. Scientific understanding of PID has evolved considerably over time, shifting from simple clinical observations to multidisciplinary investigations involving microbiology, epidemiology, immunology, and reproductive health.
Methods: This bibliographic analysis was conducted through a qualitative review of peer-reviewed articles, epidemiological studies, clinical guidelines, systematic reviews, and meta-analyses published between 2000 and 2025. Literature was collected from PubMed, Google Scholar, ScienceDirect, and reports published by the World Health Organization and the Centers for Disease Control and Prevention. Studies related to PID etiology, diagnosis, treatment, prevention, antimicrobial resistance, and reproductive complications were analyzed thematically.
Results: The analysis identified Chlamydia trachomatis and Neisseria gonorrhoeae as the primary pathogens associated with PID, although recent studies emphasized the polymicrobial nature of the disease and the contribution of vaginal microbiome imbalance. Diagnostic challenges remain significant because many patients present with mild or asymptomatic disease. Advances in molecular diagnostic techniques, especially nucleic acid amplification tests (NAATs), have improved diagnostic accuracy. Broad-spectrum antibiotic therapy continues to represent the standard treatment approach; however, increasing antimicrobial resistance among gonococcal strains has emerged as a major concern. The reviewed literature consistently associated untreated or recurrent PID with infertility, ectopic pregnancy, chronic pelvic pain, and recurrent infections. Public health interventions, including STI screening, sexual health education, and early treatment strategies, were strongly supported for reducing disease prevalence and complications.
Conclusion: PID research has progressed substantially over recent decades, integrating clinical medicine with molecular biology and public health perspectives. Despite improvements in diagnosis and treatment, challenges related to antimicrobial resistance, healthcare disparities, and delayed diagnosis remain significant. Continued research is necessary to improve prevention strategies, diagnostic standards, and therapeutic approaches in order to reduce the global burden of PID.

Pelvic inflammatory disease (PID), Chlamydia trachomatis

1. Brunham, R. C., & Gottlieb, S. L. (2015). Pelvic inflammatory disease. New England Journal of Medicine, 372(21), 2039–2048. [Google Scholar] [Crossref]

2. Haggerty, C. L., & Ness, R. B. (2006). Diagnosis and treatment of pelvic inflammatory disease. Women's Health, 2(3), 383–397. [Google Scholar] [Crossref]

3. Ross, J., Guaschino, S., Cusini, M., Jensen, J., & Mirandola, M. (2018). 2017 European guideline for the management of pelvic inflammatory disease. International Journal of STD & AIDS, 29(2), 108–114. [Google Scholar] [Crossref]

4. Centers for Disease Control and Prevention (CDC). (2021). Sexually Transmitted Infections Treatment Guidelines. [Google Scholar] [Crossref]

5. World Health Organization (WHO). (2021). Global progress report on HIV, viral hepatitis and sexually transmitted infections. [Google Scholar] [Crossref]

6. Wiesenfeld, H. C., & Sweet, R. L. (2015). Progress in the management of pelvic inflammatory disease. Clinical Obstetrics and Gynecology, 58(2), 281–291. [Google Scholar] [Crossref]

7. Sweet, R. L. (2012). Pelvic inflammatory disease: Current concepts of diagnosis and management. Current Infectious Disease Reports, 14(2), 194–203. [Google Scholar] [Crossref]

8. Haggerty, C. L., et al. (2010). Risk of sequelae after Chlamydia trachomatis genital infection in women. Journal of Infectious Diseases, 201(S2), S134–S155. [Google Scholar] [Crossref]

9. Westrom, L., Joesoef, R., Reynolds, G., Hagdu, A., & Thompson, S. E. (1992). Pelvic inflammatory disease and fertility. Sexually Transmitted Diseases, 19(4), 185–192. [Google Scholar] [Crossref]

10. Paavonen, J., & Westrom, L. (2008). Pelvic inflammatory disease. In Sexually Transmitted Diseases (4th ed.). [Google Scholar] [Crossref]

11. Ness, R. B., et al. (2002). Effectiveness of treatment strategies of PID. American Journal of Obstetrics and Gynecology, 186(5), 929–937. [Google Scholar] [Crossref]

12. Walker, C. K., & Wiesenfeld, H. C. (2007). Antibiotic therapy for acute pelvic inflammatory disease. Clinical Infectious Diseases, 44(S3), S111–S122. [Google Scholar] [Crossref]

13. Taylor, B. D., & Darville, T. (2011). Hsp60 and PID pathogenesis. Expert Review of Anti-infective Therapy, 9(8), 759–772. [Google Scholar] [Crossref]

14. Cohen, C. R., et al. (2005). Bacterial vaginosis associated bacteria and PID. Clinical Infectious Diseases, 40(5), 669–674. [Google Scholar] [Crossref]

15. Manhart, L. E., et al. (2003). Mycoplasma genitalium: Should we treat and how? Clinical Infectious Diseases, 37(6), 748–754. [Google Scholar] [Crossref]

16. Lis, R., Rowhani-Rahbar, A., & Manhart, L. E. (2015). Mycoplasma genitalium infection and female reproductive tract disease. Clinical Infectious Diseases, 61(3), 418–426. [Google Scholar] [Crossref]

17. Wiesenfeld, H. C., et al. (2002). Lower genital tract infection and endometritis. Clinical Infectious Diseases, 34(6), 745–751. [Google Scholar] [Crossref]

18. Peipert, J. F. (2003). Clinical practice: Genital chlamydial infections. New England Journal of Medicine, 349(25), 2424–2430. [Google Scholar] [Crossref]

19. Stamm, W. E. (1999). Chlamydia trachomatis infections of the adult. In Sexually Transmitted Diseases. [Google Scholar] [Crossref]

20. Unemo, M., & Shafer, W. M. (2014). Antimicrobial resistance in Neisseria gonorrhoeae. BMC Infectious Diseases, 14, 1–13. [Google Scholar] [Crossref]

21. Wi, T., et al. (2017). Antimicrobial resistance in Neisseria gonorrhoeae. PLoS Medicine, 14(7), e1002344. [Google Scholar] [Crossref]

22. Kirkcaldy, R. D., et al. (2019). Neisseria gonorrhoeae antimicrobial resistance. Emerging Infectious Diseases, 25(11), 2109–2116. [Google Scholar] [Crossref]

23. Gottlieb, S. L., et al. (2010). Screening and prevention strategies for STIs. Lancet, 375(9718), 1764–1774. [Google Scholar] [Crossref]

24. Low, N., et al. (2006). Global control of sexually transmitted infections. Lancet, 368(9551), 2001–2016. [Google Scholar] [Crossref]

25. Tsevat, D. G., et al. (2017). Sexually transmitted diseases and infertility. American Journal of Obstetrics and Gynecology, 216(1), 1–9. [Google Scholar] [Crossref]

26. Gradison, M. (2012). Pelvic inflammatory disease. American Family Physician, 85(8), 791–796. [Google Scholar] [Crossref]

27. Brunham, R. C., Rekart, M. L., & Gottlieb, S. L. (2015). The evolving epidemiology of PID. Journal of Infectious Diseases, 211(S2), S89–S95. [Google Scholar] [Crossref]

28. Horne, A. W., et al. (2015). Ectopic pregnancy and PID. BMJ, 351, h3397. [Google Scholar] [Crossref]

29. Taylor, B. D., Haggerty, C. L., & Ness, R. B. (2011). Long-term reproductive consequences of PID. Expert Review of Obstetrics & Gynecology, 6(4), 427–438. [Google Scholar] [Crossref]

30. Eschenbach, D. A. (2008). PID: Clinical and microbiological perspectives. Journal of Infectious Diseases, 197(S2), S190–S196. [Google Scholar] [Crossref]

• Measuring Waste of Patient Time in Health Care at Non-Digitized Hospital: An Observational Study in Bangabandhu Sheikh Mujib Medical University, Bangladesh
• Reaffirming Clinical Confidence in Atorvastatin Therapy: A Digital Outreach Case Study from Tamil Nadu, India
• Clinical Manifestations and Therapeutic Response in a Patient with Hypothyroidism: A Case Report
• Eranda (Ricinus Communis) In Gridhrasi (Sciatica): Classical Rationale, Pharmacology and Clinical Evidence- A Narrative Literature Review
• Magnetotherapy in Pain Management: Mechanisms, Clinical Applications, and Future Perspectives – A Review